PETROSCRAP.COM » Results

Kraton Polymers Announces Exceptional Performance Results In

admin — Sat, 28 Jan 2012 08:12:26 +0000

Kraton Polymers Announces Exceptional Performance Results In
Houston, TX /PRNewswire/ – Kraton Performance Polymers, Inc. (NYSE: "KRA"), a leading global producer of styrenic block copolymers or "SBCs," tested performance properties of an industrial coatings starting point formulation made with Kraton™ FG1901 …
Read more on Surface Finishing.com

PolyOne Corporation – Value
PolyOne manufactures specialized polymer materials which are found in just about every industry from transportation, to colors used in packaging, to electronics and healthcare. It provides services in natural rubber latex compounds, color additives, …
Read more on NASDAQ

DuPont at Pharmapack 2012: NEW grade of low friction, low wear DuPont™ Delrin …
The range of high performance polymers available from DuPont for use in medical devices, including the new DuPont™ Delrin® SC699 acetal resin forms the focal point of the company's exhibit at Pharmapack 2012 in Paris (stand 561).
Read more on Healthcare Packaging

Albemarle's CEO Discusses Q4 2011 Results – Earnings Call Transcript

admin — Wed, 25 Jan 2012 12:12:32 +0000

Albemarle's CEO Discusses Q4 2011 Results – Earnings Call Transcript
For the full year excellent pricing, reasonably strong demands through three fourths of the year and structural initiatives allowed Polymers to deliver full year net sales in excess of $ 1 billion for the first time, up 11% year-over-year; …
Read more on Seeking Alpha

European Coronary Stent Market to Decline to 0 Million by 2016, Despite …
In biodegradable polymer stents, a polymer controls drug release but then disappears, leaving a bare metal stent. Examples of stents with biodegradable polymers are Biosensors International's BioMatrix, Terumo Medical's Nobori, Sahajanand Medical …
Read more on EON: Enhanced Online News (press release)

Novomer, Penford to work on sustainable polymers
Novomer Inc., a new materials company based in Waltham, Mass., has inked a joint development agreement on polymer composites with Penford Corp. of Colorado. The new alliance aims to speed the development and commercialization of starch-polypropylene …
Read more on Sustainable Business Oregon

Flamel Technologies Announces Projected Release Date of Second Quarter Results; Conference Call

admin — Tue, 19 Jul 2011 16:13:00 +0000

Flamel Technologies Announces Projected Release Date of Second Quarter Results; Conference Call
LYON, FRANCE–(Marketwire – Jul 18, 2011) – Flamel Technologies ( NASDAQ : FLML ) expects to release its financial results for the second quarter of 2011 on Monday, July 25 th , after the market close. A conference call to discuss the results has been scheduled for Tuesday, July 26 th , at 8:30 AM (EDT). A question and answer period is expected to follow the discussion of results.
Read more on Marketwire

AdvanSource Biomaterials Completes 0K Debt Financing
WILMINGTON, Mass.–(BUSINESS WIRE)–AdvanSource Biomaterials Corporation (OTC Markets OTCQB: ASNB), …
Read more on citybizlist Boston

Celanese Corporation Reports First Quarter 2011 Results; Raises Outlook for Remainder of Year

admin — Thu, 28 Apr 2011 04:35:18 +0000

Celanese Corporation Reports First Quarter 2011 Results; Raises Outlook for Remainder of Year
DALLAS–(BUSINESSWIRE)– Celanese Corporation : Three Months Ended March 31, (in $ millions, except per share data) – Unaudited 2011 2010 As Adjusted3 Net sales 1,589 1,388 Operating …

Silence Therapeutics – PF-04523655 Phase 2 Study Results

admin — Tue, 22 Mar 2011 08:35:01 +0000

Silence Therapeutics – PF-04523655 Phase 2 Study Results
Silence Therapeutics – PF-04523655 Phase 2 Study Results

LyondellBasell Reports Fourth-Quarter and Full Year 2010 Results

admin — Sun, 20 Feb 2011 00:34:52 +0000

LyondellBasell Reports Fourth-Quarter and Full Year 2010 Results - Read more on PR Newswire via Yahoo!.... Click Here to Read More

AdvanSource Biomaterials Announces Fiscal 2011 Second Quarter Results

admin — Fri, 19 Nov 2010 22:35:24 +0000

AdvanSource Biomaterials Announces Fiscal 2011 Second Quarter Results
WILMINGTON, Mass.–(BUSINESS WIRE)–AdvanSource Biomaterials Corporation (NYSE Amex: ASB), a leading developer of advanced polymer materials for a broad range of medical devices, today announced financial results for its fiscal 2011 second quarter ended September 30, 2010. Total revenues for the three months ended September 30, 2010 were $491,000 as compared with $518,000 for the comparable …

Dow Reports Third Quarter Results

admin — Sun, 31 Oct 2010 10:35:06 +0000

Dow Reports Third Quarter Results
MIDLAND, Mich.–(BUSINESS WIRE)–The Dow Chemical Company (NYSE: DOW): Third Quarter 2010 Highlights Dow reported earnings of $0.45 per share. The Company delivered earnings of $0.54 per share excluding certain items,(3) compared with earnings of $0.24 per share in the year-ago period excluding certain items and discontinued operations. EBITDA(2) rose more than $350 million to more than $1.9 …

PolyMedix to Review Results from Recent Phase 1B LMWH Reversal Clinical Study with Heptagonist PMX-60056

admin — Thu, 10 Jun 2010 10:34:57 +0000

PolyMedix to Review Results from Recent Phase 1B LMWH Reversal Clinical Study with Heptagonist PMX-60056 RADNOR, Pa.----PolyMedix, Inc. , an emerging bio-technology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has scheduled a webcast for Wednesday, June 9 at 4:00 PM Eastern Time. Read more on Business Wire via Yahoo!.... Click Here to Read More

Elixir Medical Corporation Announces Excellent Nine Month Safety And Efficacy Results From The EXCELLA II Randomized …

admin — Tue, 01 Jun 2010 18:35:46 +0000

Elixir Medical Corporation Announces Excellent Nine Month Safety And Efficacy Results From The EXCELLA II Randomized ... Elixir Medical Corporation, a developer of product platforms combining state-of-the-art medical devices with advanced pharmaceuticals, announced today the superiority of the Elixir DESyne stent compared to the control Endeavor stent in the primary endpoint of the EXCELLA II randomized clinical trial. The Elixir DESyne Stent is the first drug eluting stent with the thinnest durable polymer ... Read more on Medical News.... Click Here to Read More